Results summary | View all lists in L2L MDB | View all genes in P02C.profile.u50 |
Down-regulated at 24 hr following treatment of peripheral blood mononuclear cells (PBMC) with recombinant IL-2. enrichment: 3.76-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
207535_S_AT | NFKB2 | R | S | ![]() |
![]() |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | |||||||
203372_S_AT | SOCS2 | G | S | ![]() |
![]() |
suppressor of cytokine signaling 2 | |||||||
205193_AT | MAFF | D | R | ![]() |
![]() |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | |||||||
205479_S_AT | PLAU | X | P | S | ![]() |
![]() |
plasminogen activator, urokinase | ||||||
212811_X_AT | SLC1A4 | T | ![]() |
![]() |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | ||||||||
209774_X_AT | CXCL2 | X | S | ![]() |
![]() |
chemokine (C-X-C motif) ligand 2 |